6640--Oroboros NexGen X | X | OROBOROS INSTRUMENTS CORP

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 intends to award a sole source contract to Oroboros Instruments GmbH of Innsbruck, Austria for specialized scientific research equipment to be installed at the Providence VA Medical Center. The procurement involves two specific Oroboros instruments: the Power NextGen-O2k Redox, Series XB and the NextGen-O2k Redox, Series XB, which are high-resolution scientific instruments designed to study mitochondrial respiration and are critical for research investigating mitochondrial dysfunction in diseases affecting veterans. The VA is pursuing this procurement under FAR 6.302.1-1, citing that only one responsible source exists and no other supplies or services will satisfy the agency requirements, as Oroboros Instruments is the exclusive vendor for these specific scientific instruments. The procurement falls under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1,000 employees and Product Service Code 6640 (Laboratory Equipment and Supplies). Interested parties must submit responses by August 21, 2025, no later than 10:00 AM EST, and should contact the Contracting Specialist at andrew.simard@va.gov with any questions regarding this procurement.

This procurement does not utilize any set-aside designations and is structured as a sole source award to Oroboros Instruments GmbH, making them both the intended contractor and the exclusive source for the required equipment. The contract includes a one-year performance period with the equipment to be installed in Research Building 35 at the Providence VA Medical Center, and the instruments will not be connected to VA networks for security purposes. The procurement includes a 36-month manufacturer warranty as part of the contract terms, ensuring long-term support for the specialized research equipment. While specific award values are not disclosed in the pre-solicitation notice, the procurement represents a significant investment in mitochondrial research capabilities at the VA medical facility. The equipment acquisition supports the VA's research mission focused on understanding mitochondrial dysfunction and its relationship to various diseases that affect the veteran population.